Ramírez-Tirado LA, Uribe-Ortiz CE, Arrieta O, Tirado-Gómez LL

Language: English
References: 22
Page: 249-256
PDF size: 402.67 Kb.

ABSTRACT

Objective. To analyze the mortality trend of lung cancer (LC) in Mexico, according to the municipality marginalization index (MMI) by age group and sex, during the period 1998-2016. Materials and methods. The information on mortality, population and MMI was obtained from the National Institute of Statistics and Geography (INEGI) and the National Council of Population (Conapo). The adjusted LC mortality rate trends were analyzed using the joinpoint regression analysis. A total of 126 132 deaths were included. Results. The adjusted LC mortality rate decreased from 7.83 to 4.97 100 000 inhabitants during the period from 1998-2016, but the decrease was found to be less in women and in areas with very high marginalization. Conclusions. Unequal reduction in LC mortality according to the degree of marginalization are related to early diagnosis, timely treatment and inequity in medical services. This inequity affects mainly the populations of women, highly marginalized groups and older populations.

REFERENCES

1. International Agency for Research in Cancer. The Global Cancer Observatory [internet]. Lyon: IARC; c2019 [cited Oct 20, 2018]. Available from: http://globocan.iarc.fr

2. Arrieta O, Guzmán-de Alba E, Alba-López LF, Acosta-Espinoza A, Alatorre-Alexander J, Alexander-Meza JF, et al. National consensus of diagnosis and treatment of non-small cell lung cancer. Rev Invest Clin. 2013;65(suppl 1):S5-84.

3. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Secretaría de Salud. Encuesta Nacional de Adicciones 2011: Reporte de tabaco. Mexico City: INPRFM, 2012. Available from: http://www.conadic.salud.gob. mx/pdfs/ENA_2011_TABACO.pdf

4. Hernández-Garduño E, Gómez-García E, Campos-Gómez S. Prevalence trends of wood use as the main cooking fuel in Mexico, 1990-2013. Salud Publica Mex. 2017;59(1):68-75. https://doi.org/10.21149/7770

5. Arrieta O, Campos-Parra AD, Zuloaga C, Avilés A, Sánchez-Reyes R, Manríquez ME, et al. Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure. J Thorac Oncol. 2012;7(8):1228-34. https://doi. org/10.1097/JTO.0b013e3182582a93

6. Jacobsen MM, Silverstein SC, Quinn M, Waterston LB, Thomas CA, Benneyan JC, et al. Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review. Lung cancer. 2017;112:156-64. https://doi.org/10.1016/j.lungcan.2017.08.011

7. Nadpara PA, Madhavan SS, Trorek C. Disparities in lung cancer care and outcomes among elderly in a medically underserved state population— A cancer registry-linked database study. Popul Health Manag. 2016;19(2):109-19. https://doi.org/10.1089/pop.2015.0027

8. Maguire FB, Morris CR, Parikh-Patel A, Cress RD, Keegan THM, Li CS, et al. Disparities in systemic treatment use in advanced-stage non-small cell lung cancer by source of health insurance. Cancer Epidemiol Biomarkers Prev. 2019;28(6):1059-66. https://doi.org//10.1158/1055-9965.EPI-18-0823

9. Urbina-Fuentes M. Marginación, desarrollo regional y salud. Gac Med Mex. 1996;132(6):577-83.

10. Alexander GL, Kinman EL, Miller LC, Patrick TB. Marginalization and health geomatics. J Biomed Inform. 2003;36(4-5):400-7. https://doi. org/10.1016/j.jbi.2003.09.021

11. Consejo Nacional de Población. Proyecciones de la población de México, 1990-2010, 2010-2050. México: Conapo [cited Nov 2017]. Available fron: https://www.gob.mx/cms/uploads/attachment/file/63977/Documento_ Metodologico_Proyecciones_Mexico_2010_2050.pdf

12. Dirección General de Información en Salud. Base de datos de defunciones 1979-2011 [internet]. Mexico: Secretaría de Salud [cited Nov 2017]. Available from: http://www.dgis.salud.gob.mx/contenidos/basesdedatos/ std_defunciones_gobmx.html

13. World Health Organización. International classification of disease and related health problems: 10th revision. Geneva: World Health Organization, 1992.

14. Li T, Kung HJ, Mack PC, Gandara DR. Genotyping and genomic profiling of non-small cell lung cancer: implications for current and future therapies. J Clin Oncol. 2013;31(8):1039-49. https://doi.org/10.1200/ JCO.2012.45.3753

15. Yang R, Cheung MC, Byrne MM, Huang Y, Ngoyen D, Lally BE, Konany LG. Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer. 2010;116(10):2437-47. https://doi.org/10.1002/cncr.24986

16. Forrest LF, Adams J, Wareham H, Rubin G, White M. Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis thorax. PLoS Med. 2013;10(2):e1001376. https://doi.org/10.1371/journal. pmed.1001376

17. Forrest LF, Sowden S, Rubin G, White M, Adams J. Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysis. Thorax. 2017;72(5):430-36. https://doi.org/10.1136/thoraxjnl- 2016-209013

18. Hernández-Garduño E, Ocaña-Servín HL. Lung cancer mortality trends in Mexico, 1999–2014. Salud Publica Mex. 2018;60(3)366-9. https://doi. org/10.21149/8730

19. Raez LE, Cardona AF, Santos ES, Catoe H, Rolfo C, Lopes G, et al. The burden of lung cancer in Latin America and challenges in the access to genomic profiling, immunotherapy and targeted treatments. Lung Cancer. 2018;119:7-13. https://doi.org/10.1016/j.lungcan.2018.02.014

20. Arrieta O, López-Mejía M, Macedo-Pérez EO, Corona-Cruz JF. Proposals for the prevention of lung cancer in the health system of Mexico. Salud Publica Mex. 2016; 58(2):274-8. https://doi.org/10.21149/spm. v58i2.7796

21. Diario Oficial de la Fedaración. Ley de Impuesto Especial sobre Producción y Servicios. Mexico Dec 20, 2006.

22. Gaceta Oficial del Distrito Federal. Ley de Protección a la Salud de los No Fumadores en el Distrito Fedral Aprobada por la Asamblea Legislativa del Distrito Federal el 26 de febrero. Mexico Mar 4, 2008.